Literature DB >> 6083115

Kinetic considerations relating to the use of drug precursors.

B K Martin.   

Abstract

Mesh:

Substances:

Year:  1967        PMID: 6083115      PMCID: PMC1557335          DOI: 10.1111/j.1476-5381.1967.tb00409.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


× No keyword cloud information.
  10 in total

1.  PREDICTION OF MULTIPLE DOSE SERUM LEVELS OF 'LINCOCIN' FROM SINGLE DOSE SERUM LEVELS WHEN 'LINOCIN' (AS THE HYDROCHLORIDE) WAS ADMINISTERED BY CONSTANT RATE INTRAVENOUS INFUSION.

Authors:  J G WAGNER; C D ALWAY
Journal:  Nature       Date:  1964-03-14       Impact factor: 49.962

2.  EXCRETION AND THE ACCRUAL OF DRUG METABOLITES.

Authors:  A J CUMMINGS; B K MARTIN
Journal:  Nature       Date:  1963-12-28       Impact factor: 49.962

3.  Dosage schedule and pharmacokinetics in chemotherapy.

Authors:  E KRUEGER-THIEMER
Journal:  J Am Pharm Assoc Am Pharm Assoc       Date:  1960-05

4.  Sulfaethylthiadiazole. IV. Steady state blood concentration and urinary excretion data following repeated oral doses.

Authors:  J V SWINTOSKY; A BONDI; M J ROBINSON
Journal:  J Am Pharm Assoc Am Pharm Assoc       Date:  1958-10

5.  Drug latentiation.

Authors:  N J HARPER
Journal:  J Med Pharm Chem       Date:  1959-10

6.  Chemical aspects of selective toxicity.

Authors:  A ALBERT
Journal:  Nature       Date:  1958-08-16       Impact factor: 49.962

7.  Proguanil, the isolation of a metabolite with high antimalarial activity.

Authors:  A F CROWTHER; A A LEVI
Journal:  Br J Pharmacol Chemother       Date:  1953-03

8.  Blood levels of drug at the equilibrium state after multiple dosing.

Authors:  J G Wagner; J I Northam; C D Alway; O S Carpenter
Journal:  Nature       Date:  1965-09-18       Impact factor: 49.962

9.  Kinetic considerations relating to the accrual and elimination of drug metabolites.

Authors:  A J Cummings; B K Martin; G S Park
Journal:  Br J Pharmacol Chemother       Date:  1967-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.